Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

2.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

1.2K
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

549
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
549
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

33
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
33
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

28
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The management of subglottic stenosis in patients with Wegener's granulomatosis.

The Laryngoscope·1992
Same author

The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate.

Arthritis and rheumatism·1992
Same author

Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.

The Journal of experimental medicine·1992
Same author

CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals.

Journal of immunology (Baltimore, Md. : 1950)·1992
Same author

Lymphokine production by B cells from normal and HIV-infected individuals.

Annals of the New York Academy of Sciences·1992
Same author

Pharmacologic regulation of HIV expression.

AIDS research and human retroviruses·1992

Related Experiment Video

Updated: May 5, 2026

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

7.2K

Sjögren's syndrome (Sicca syndrome): current issues

H M Moutsopoulos, T M Chused, D L Mann

    Annals of Internal Medicine
    |February 1, 1980
    PubMed
    Summary

    This study compares primary Sjögren's syndrome to secondary Sjögren's syndrome in rheumatoid arthritis and lupus. It details immune system regulation and immune complex clearance in Sjögren's syndrome.

    More Related Videos

    Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
    05:26

    Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

    Published on: March 1, 2024

    2.5K
    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
    10:21

    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

    Published on: September 20, 2024

    915

    Related Experiment Videos

    Last Updated: May 5, 2026

    Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
    07:25

    Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

    Published on: October 13, 2023

    7.2K
    Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
    05:26

    Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

    Published on: March 1, 2024

    2.5K
    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
    10:21

    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

    Published on: September 20, 2024

    915

    Area of Science:

    • Immunology
    • Rheumatology
    • Clinical Medicine

    Background:

    • Sjögren's syndrome can occur alone (primary) or with other autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus (secondary).
    • Understanding the differences and similarities between these forms is crucial for diagnosis and treatment.
    • Immune system dysregulation is a hallmark of Sjögren's syndrome.

    Purpose of the Study:

    • To delineate the clinical, serologic, and immunogenetic distinctions and commonalities between primary and secondary Sjögren's syndrome.
    • To explore the mechanisms of immunoregulation in Sjögren's syndrome.
    • To investigate the role and clearance of immune complex-like material in the pathophysiology of Sjögren's syndrome.

    Main Methods:

    • Comparative analysis of clinical, serologic, and immunogenetic data.
    • Discussion of immunoregulation pathways.
    • Presentation of data on immune complex-like material, its nature, and clearance mechanisms.

    Main Results:

    • Identified key differences and similarities in clinical presentation, serology, and immunogenetics between primary and secondary Sjögren's syndrome.
    • Elucidated aspects of immune dysregulation specific to Sjögren's syndrome.
    • Described the presence, characteristics, and clearance of immune complex-like material via the Fc receptor of the reticuloendothelial system.

    Conclusions:

    • Primary and secondary Sjögren's syndrome exhibit distinct yet overlapping features, necessitating tailored clinical approaches.
    • Immune complex pathophysiology and clearance mechanisms are integral to understanding Sjögren's syndrome.
    • Further research into immunoregulation can inform therapeutic strategies for Sjögren's syndrome and associated conditions.